CEACAM5 and malignant mesothelioma: The complete CEA-negativity of all our 90 malignant mesotheliomas while 74% of the 179 pulmonary adenocarcinomas were CEA-positive supports the use of CEA IHC for the distinction of malignant mesothelioma from pulmonary adenocarcinoma.